MedPath

RCT to Examine the Effects of Scanning

Not Applicable
Completed
Conditions
Colorectal Cancer
Cancer
Breast Cancer
Registration Number
NCT01804621
Lead Sponsor
University of Pennsylvania
Brief Summary

The purpose of the study is to implement a randomized control trial testing effects of information scanning on cancer prevention and screening behaviors in a population sample of 50-70 year olds. Participants will receive one of five versions of an e-newsletter once/month for 12 months and will be asked to complete baseline, mid-point, and end-of-project surveys.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15824
Inclusion Criteria
  • US adults, male or female, between 50 and 70 years of age.
Exclusion Criteria
  • Potential subjects will be excluded if they are not between the ages of 50 and 70

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fruit & Vegetable Consumption12 months

Total daily servings of reported fruits and vegetables (maximum of 10) were calculated using a composite measure that summed separate responses for fruits and vegetables.

Colorectal cancer screening12 months

A measure of up-to-date colorectal cancer screening status was assessed using individuals' self-reports of recency of colonoscopy (within 10 years), sigmoidoscopy (within five years), and/or fecal occult blood test (FOBT) within one year.

Mammography Screening Behavior12 months

We used responses to two questions to create a dichotomous measure of whether or not female respondents (all aged 50 to 70) received a mammogram in the past year.

Exercise Behavior12 months

The Godin Scale was used to assess weekly exercise frequency and intensity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.